Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Karsten Midtvedt, MD"'
Autor:
Jørn Petter Lindahl, MD, PhD, Anders Åsberg, MD, PhD, Kristian Heldal, MD, PhD, Trond Jenssen, MD, PhD, Christina Dörje, MD, PhD, Morten Skauby, MD, Karsten Midtvedt, MD, PhD
Publikováno v:
Transplantation Direct, Vol 10, Iss 7, p e1660 (2024)
Background. Transplantation of kidneys from elderly donations after brain death (DBD) donors has increased owing to organ shortages. We aimed to assess the impact on long-term kidney transplant outcomes from DBD donors aged 70 y and older compared wi
Externí odkaz:
https://doaj.org/article/1769bc3fe0a54977a19a459b95a5b505
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 8, Iss 4, Pp 657-659 (2022)
Recent studies have reported that components of the renin-angiotensin system (RAS) are expressed in venous malformations by embryonic stem cell-like subpopulations. It has been hypothesized that these cells are sustained by the RAS and, therefore, co
Externí odkaz:
https://doaj.org/article/105084adfb894c0984481ab05605ad9e
Autor:
Ole Martin Drevland, MSc, Ida Robertsen, PhD, Marte Theie Gustavsen, PhD, Hanne Kamilla Kveim, MSc, Markus Herberg Hovd, MSc, Karsten Midtvedt, MD, PhD, Anders Åsberg, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 3, p e1448 (2023)
Background. Mycophenolate mofetil (MMF) is an immunosuppressive prodrug often used to prevent allograft rejection following solid organ transplantation. After oral administration, MMF is rapidly hydrolyzed to the active metabolite mycophenolate acid
Externí odkaz:
https://doaj.org/article/9550784b2a534c2389fd42020600e6ce
Autor:
Olivier Aubert, MD, Daniel Yoo, MPH, Dina Zielinski, PhD, Emanuele Cozzi, MD, Massimo Cardillo, MD, Michael Dürr, MD, Beatriz Domínguez-Gil, MD, Elisabeth Coll, MD, Margarida Ivo Da Silva, MD, Ville Sallinen, MD, Karl Lemström, MD, Karsten Midtvedt, MD, Camilo Ulloa, MD, Franz Immer, MD, Annemarie Weissenbacher, MD, Natalie Vallant, MD, Nikolina Basic-Jukic, MD, Kazunari Tanabe, MD, Georgios Papatheodoridis, PhD, Georgia Menoudakou, MSc, Martin Torres, MD, Carlos Soratti, MD, Daniela Hansen Krogh, Carmen Lefaucheur, MD, Gustavo Ferreira, MD, Helio Tedesco Silva, Jr, MD, David Hartell, MA, John Forsythe, MD, Lisa Mumford, MSc, Peter P Reese, MD, François Kerbaul, MD, Christian Jacquelinet, MD, Serge Vogelaar, MD, Vassilios Papalois, MD, Alexandre Loupy, MD
Publikováno v:
The Lancet Public Health, Vol 6, Iss 10, Pp e709-e719 (2021)
Summary: Background: Preliminary data suggest that COVID-19 has reduced access to solid organ transplantation. However, the global consequences of the COVID-19 pandemic on transplantation rates and the effect on waitlisted patients have not been repo
Externí odkaz:
https://doaj.org/article/eb04f7c21b8347bd8e36f5a796f765ba
Autor:
Mari O. Onsøien, Karsten Midtvedt, MD, PhD, Anna V. Reisæter, MD, PhD, Knut Aasarød, MD, PhD, Bård Waldum-Grevbo, MD, PhD, Bjørn Egil Vikse, MD, PhD, Bjørn Odvar Eriksen, MD, PhD, Anders Åsberg, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 4, p e688 (2021)
Background. Hypertension in kidney transplant (KTx) recipients is common, affecting both patient and graft survival. Annual data from the Norwegian Renal Registry reveal that 18 y) KTx recipients reach target blood pressure (BP) ≤130/80 mm Hg. The
Externí odkaz:
https://doaj.org/article/d48f5a1cccf94c50b91fde104edfc642
Autor:
Anders Åsberg, PhD, Stein Bergan, PhD, Magnus H. Bjørkto, MD, Geir Mjøen, MD, PhD, Anna Varberg Reisæter, MD, PhD, Ida Robertsen, PhD, Karsten Midtvedt, MD, PhD
Publikováno v:
Transplantation Direct, Vol 6, Iss 10, p e609 (2020)
Externí odkaz:
https://doaj.org/article/99bf662d935f4841bc63e88822fe6b55
Autor:
Stein Foss, RN, Espen Nordheim, MD, Dag W. Sørensen, MD, Torgunn B. Syversen, RN, Karsten Midtvedt, MD, PhD, Anders Åsberg, PhD, Thorleif Dahl, RN, Per A. Bakkan, RN, Aksel E. Foss, MD, PhD, Odd R. Geiran, MD, PhD, Arnt E. Fiane, MD, PhD, Pål-Dag Line, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 7, p e366 (2018)
Background. Donation after circulatory death (DCD) can increase the pool of available organs for transplantation. This pilot study evaluates the implementation of a controlled DCD (cDCD) protocol using normothermic regional perfusion in Norway. Metho
Externí odkaz:
https://doaj.org/article/0a15cc8c40f04e8e8f837cd5b635a248
Autor:
Kjersti Lønning, RN, Msm, Kristian Heldal, MD, PhD, Tomm Bernklev, PhD, Cathrine Brunborg, MSc, Marit Helen Andersen, RN, PhD, Nanna von der Lippe, MD, Anna Varberg Reisæter, MD, PhD, Pål-Dag Line, MD, PhD, Anders Hartmann, MD, PhD, Karsten Midtvedt, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 4, p e351 (2018)
Background. We aimed to evaluate changes in health-related quality of life (HRQoL) in patients 65 years or older from time of kidney transplantation (KTx) until 1 year postengraftment. Methods. A single-center prospective study was conducted. HRQoL w
Externí odkaz:
https://doaj.org/article/bd9d2236461e4544a57c737f7f584a61